149 related articles for article (PubMed ID: 15806571)
1. Availability of conjugated ganglioside GD2 monoclonal antibody.
Warzynski MJ; Roys JL; Peterson JW; DeLa Vega H
Cytometry B Clin Cytom; 2005 May; 65(1):42-3. PubMed ID: 15806571
[No Abstract] [Full Text] [Related]
2. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.
Warzynski MJ; Graham DM; Axtell RA; Higgins JV; Hammers YA
Cytometry; 2002 Dec; 50(6):298-304. PubMed ID: 12497591
[TBL] [Abstract][Full Text] [Related]
3. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
[TBL] [Abstract][Full Text] [Related]
4. In vitro photothermal destruction of neuroblastoma cells using carbon nanotubes conjugated with GD2 monoclonal antibody.
Wang CH; Huang YJ; Chang CW; Hsu WM; Peng CA
Nanotechnology; 2009 Aug; 20(31):315101. PubMed ID: 19597244
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
6. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic characterization of CD34(pos) cells.
Keeney M; Brown W; Gratama J; Papa S; Lanza F; Sutherland DR;
J Biol Regul Homeost Agents; 2003; 17(3):254-60. PubMed ID: 14524611
[No Abstract] [Full Text] [Related]
8. Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.
Heiss P; Bermatz S; Wehnes H; Heinzmann U; Senekowitsch-Schmidtke R
Anticancer Res; 1997; 17(4B):3145-7. PubMed ID: 9329622
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.
Saito M; Yu RK; Cheung NK
Biochem Biophys Res Commun; 1985 Feb; 127(1):1-7. PubMed ID: 2579648
[TBL] [Abstract][Full Text] [Related]
10. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS.
Calvelli T; Denny TN; Paxton H; Gelman R; Kagan J
Cytometry; 1993 Oct; 14(7):702-15. PubMed ID: 8243200
[No Abstract] [Full Text] [Related]
11. Titering antibodies.
Stewart CC; Stewart SJ
Curr Protoc Cytom; 2001 May; Chapter 4():Unit 4.1. PubMed ID: 18770707
[TBL] [Abstract][Full Text] [Related]
12. In the realm for standardization in immunophenotyping.
Tárnok A
Cytometry A; 2012 Nov; 81(11):931-2. PubMed ID: 23090894
[No Abstract] [Full Text] [Related]
13. Comparison of immunocytochemistry, real-time quantitative RT-PCR and flow cytometry for detection of minimal residual disease in neuroblastoma.
Ifversen MR; Kågedal B; Christensen LD; Rechnitzer C; Petersen BL; Heilmann C
Int J Oncol; 2005 Jul; 27(1):121-9. PubMed ID: 15942651
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effect of immunoconjugate composed of glucose-oxidase coupled to an anti-ganglioside (GD2) antibody on spheroids.
Heiss P; Bernatz S; Bruchelt G; Senekowitsch-Schmidtke R
Anticancer Res; 1997; 17(4B):3177-8. PubMed ID: 9329630
[TBL] [Abstract][Full Text] [Related]
15. Setting up and calibration of a flow cytometer for multicolor immunophenotyping.
Kraan J; Gratama JW; Keeney M; D'Hautcourt JL
J Biol Regul Homeost Agents; 2003; 17(3):223-33. PubMed ID: 14524607
[No Abstract] [Full Text] [Related]
16. Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma.
Cheung NK; Miraldi FD
Prog Clin Biol Res; 1988; 271():595-604. PubMed ID: 3406022
[No Abstract] [Full Text] [Related]
17. Multiparameter flow cytometry.
Stewart CC
J Immunoassay; 2000; 21(2-3):255-72. PubMed ID: 10929889
[No Abstract] [Full Text] [Related]
18. Optimizing a multicolor immunophenotyping assay.
Mahnke YD; Roederer M
Clin Lab Med; 2007 Sep; 27(3):469-85, v. PubMed ID: 17658403
[TBL] [Abstract][Full Text] [Related]
19. [Immunoradionuclide localization of human neuroblastoma xenografted in nude mice using anti-GD2 labelled with I125].
Perdereau B; Barbaroux C; Michon J; Fridman WH; Rosin N; Validire P; Zucker JM; Manil L
Bull Cancer; 1994 Jul; 81(7):593-8. PubMed ID: 7742601
[TBL] [Abstract][Full Text] [Related]
20. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS.
Schnizlein-Bick CT; Mandy FF; O'Gorman MR; Paxton H; Nicholson JK; Hultin LE; Gelman RS; Wilkening CL; Livnat D
Cytometry; 2002 Apr; 50(2):46-52. PubMed ID: 12116345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
